PET ¹⁸F-flurpridaz quantitative measurements of myocardial blood flow: Added value for diagnosis of coronary artery disease? Of course!

J Nucl Cardiol. 2021 Oct;28(5):2330-2334. doi: 10.1007/s12350-020-02043-1. Epub 2020 Feb 4.

Author

Henry Gewirtz^{1

2}

Affiliations

¹ Department of Medicine (Cardiology Division), Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA. gewirtz.henry@mgh.harvard.edu.
² Cardiac Unit, Massachusetts General Hospital, Boston, MA, 02114, USA. gewirtz.henry@mgh.harvard.edu.

PMID: 32020502
DOI: 10.1007/s12350-020-02043-1

No abstract available

Publication types

Editorial

MeSH terms

Coronary Artery Disease / diagnostic imaging*
Coronary Artery Disease / physiopathology
Fractional Flow Reserve, Myocardial
Humans
Myocardial Perfusion Imaging*
Positron-Emission Tomography*
Predictive Value of Tests
Pyridazines*
Reproducibility of Results
Retrospective Studies

Substances

BMS 747158-02
Pyridazines